PortfoliosLab logoPortfoliosLab logo
WEBNF vs. CHGCY
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

WEBNF vs. CHGCY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Westpac Banking Corp (WEBNF) and Chugai Pharmaceutical Co Ltd ADR (CHGCY). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

WEBNF vs. CHGCY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
WEBNF
Westpac Banking Corp
6.36%39.75%34.48%5.37%10.13%52.61%-8.36%6.69%-16.10%23.08%
CHGCY
Chugai Pharmaceutical Co Ltd ADR
11.42%21.53%17.55%48.78%-21.63%-38.50%72.01%59.87%13.53%72.59%

Fundamentals

Market Cap

WEBNF:

$65.19B

CHGCY:

$96.34B

EPS

WEBNF:

$5.20

CHGCY:

$138.25

PE Ratio

WEBNF:

5.14

CHGCY:

0.21

PS Ratio

WEBNF:

1.29

CHGCY:

0.08

PB Ratio

WEBNF:

1.36

CHGCY:

0.05

Total Revenue (TTM)

WEBNF:

$50.58B

CHGCY:

$1.27T

Gross Profit (TTM)

WEBNF:

$77.69B

CHGCY:

$937.60B

EBITDA (TTM)

WEBNF:

$3.05B

CHGCY:

$661.98B

Returns By Period

In the year-to-date period, WEBNF achieves a 6.36% return, which is significantly lower than CHGCY's 11.42% return. Over the past 10 years, WEBNF has underperformed CHGCY with an annualized return of 13.89%, while CHGCY has yielded a comparatively higher 19.94% annualized return.


WEBNF

1D
-6.79%
1M
-10.39%
YTD
6.36%
6M
9.49%
1Y
48.24%
3Y*
32.09%
5Y*
22.16%
10Y*
13.89%

CHGCY

1D
6.36%
1M
-9.01%
YTD
11.42%
6M
26.71%
1Y
31.64%
3Y*
34.69%
5Y*
8.26%
10Y*
19.94%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Westpac Banking Corp

Chugai Pharmaceutical Co Ltd ADR

Often compared with CHGCY:
CHGCY vs. GSK

Return for Risk

WEBNF vs. CHGCY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WEBNF
WEBNF Risk / Return Rank: 7373
Overall Rank
WEBNF Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
WEBNF Sortino Ratio Rank: 6767
Sortino Ratio Rank
WEBNF Omega Ratio Rank: 6969
Omega Ratio Rank
WEBNF Calmar Ratio Rank: 7777
Calmar Ratio Rank
WEBNF Martin Ratio Rank: 8181
Martin Ratio Rank

CHGCY
CHGCY Risk / Return Rank: 6161
Overall Rank
CHGCY Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
CHGCY Sortino Ratio Rank: 6060
Sortino Ratio Rank
CHGCY Omega Ratio Rank: 6161
Omega Ratio Rank
CHGCY Calmar Ratio Rank: 6060
Calmar Ratio Rank
CHGCY Martin Ratio Rank: 5858
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WEBNF vs. CHGCY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Westpac Banking Corp (WEBNF) and Chugai Pharmaceutical Co Ltd ADR (CHGCY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


WEBNFCHGCYDifference

Sharpe ratio

Return per unit of total volatility

0.86

0.69

+0.17

Sortino ratio

Return per unit of downside risk

1.52

1.24

+0.28

Omega ratio

Gain probability vs. loss probability

1.22

1.17

+0.05

Calmar ratio

Return relative to maximum drawdown

2.15

0.95

+1.20

Martin ratio

Return relative to average drawdown

6.70

1.87

+4.83

WEBNF vs. CHGCY - Sharpe Ratio Comparison

The current WEBNF Sharpe Ratio is 0.86, which is comparable to the CHGCY Sharpe Ratio of 0.69. The chart below compares the historical Sharpe Ratios of WEBNF and CHGCY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


WEBNFCHGCYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.86

0.69

+0.17

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.52

0.25

+0.27

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.36

0.62

-0.26

Sharpe Ratio (All Time)

Calculated using the full available price history

0.19

0.58

-0.39

Correlation

The correlation between WEBNF and CHGCY is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

WEBNF vs. CHGCY - Dividend Comparison

WEBNF's dividend yield for the trailing twelve months is around 2.61%, more than CHGCY's 1.45% yield.


TTM20252024202320222021202020192018201720162015
WEBNF
Westpac Banking Corp
2.61%2.78%8.39%8.91%7.82%42.62%3.83%14.51%19.31%16.01%0.00%0.00%
CHGCY
Chugai Pharmaceutical Co Ltd ADR
1.45%1.62%0.86%0.00%1.19%0.00%0.00%0.00%0.00%0.00%1.64%1.41%

Drawdowns

WEBNF vs. CHGCY - Drawdown Comparison

The maximum WEBNF drawdown since its inception was -66.96%, which is greater than CHGCY's maximum drawdown of -59.68%. Use the drawdown chart below to compare losses from any high point for WEBNF and CHGCY.


Loading graphics...

Drawdown Indicators


WEBNFCHGCYDifference

Max Drawdown

Largest peak-to-trough decline

-66.96%

-59.68%

-7.28%

Max Drawdown (1Y)

Largest decline over 1 year

-18.99%

-32.48%

+13.49%

Max Drawdown (5Y)

Largest decline over 5 years

-31.26%

-45.45%

+14.19%

Max Drawdown (10Y)

Largest decline over 10 years

-61.21%

-59.68%

-1.53%

Current Drawdown

Current decline from peak

-12.50%

-12.91%

+0.41%

Average Drawdown

Average peak-to-trough decline

-21.11%

-16.00%

-5.11%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.09%

16.49%

-10.40%

Volatility

WEBNF vs. CHGCY - Volatility Comparison

The current volatility for Westpac Banking Corp (WEBNF) is 11.28%, while Chugai Pharmaceutical Co Ltd ADR (CHGCY) has a volatility of 12.49%. This indicates that WEBNF experiences smaller price fluctuations and is considered to be less risky than CHGCY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


WEBNFCHGCYDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.28%

12.49%

-1.21%

Volatility (6M)

Calculated over the trailing 6-month period

31.69%

26.89%

+4.80%

Volatility (1Y)

Calculated over the trailing 1-year period

56.65%

45.96%

+10.69%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

42.67%

33.36%

+9.31%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

39.13%

32.31%

+6.82%

Financials

WEBNF vs. CHGCY - Financials Comparison

This section allows you to compare key financial metrics between Westpac Banking Corp and Chugai Pharmaceutical Co Ltd ADR. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00B200.00B300.00B400.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
18.98B
352.55B
(WEBNF) Total Revenue
(CHGCY) Total Revenue
Values in USD except per share items

WEBNF vs. CHGCY - Profitability Comparison

The chart below illustrates the profitability comparison between Westpac Banking Corp and Chugai Pharmaceutical Co Ltd ADR over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober0
84.5%
Portfolio components
WEBNF - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Westpac Banking Corp reported a gross profit of 0.00 and revenue of 18.98B. Therefore, the gross margin over that period was 0.0%.

CHGCY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Chugai Pharmaceutical Co Ltd ADR reported a gross profit of 298.03B and revenue of 352.55B. Therefore, the gross margin over that period was 84.5%.

WEBNF - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Westpac Banking Corp reported an operating income of 1.16B and revenue of 18.98B, resulting in an operating margin of 6.1%.

CHGCY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Chugai Pharmaceutical Co Ltd ADR reported an operating income of 172.47B and revenue of 352.55B, resulting in an operating margin of 48.9%.

WEBNF - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Westpac Banking Corp reported a net income of 2.38B and revenue of 18.98B, resulting in a net margin of 12.5%.

CHGCY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Chugai Pharmaceutical Co Ltd ADR reported a net income of 147.51B and revenue of 352.55B, resulting in a net margin of 41.8%.